54th Annual General Meeting of the P-D-R 2012
Pharmaceutical companies will be better able to pursue research using text and data-mining, thanks to an agreement announced today. The Pharma-Documentation-Ring(P-D-R)sample license has been updated to grant text and data-mining rights to use the content to which each of the P-D-R members subscribes. The P-D-R sample license serves as a benchmark used by P-D-R’s members to negotiate individual subscription agreements with publishers and other content suppliers. It is regularly updated to enable market demand to meet at the intersection of pharmaceutical research, bio-informatics as well as electronic and scientific publishing.